Next Webcast

Abiomed Fiscal Second Quarter 2007 Earnings
Wednesday November 8, 2006
4:30 pm ET
Click here to listen

The Abiomed Opportunity:
Today:

• Market leader in heart assist for recovery with large installed base, exclusive recovery indications
  and improved reimbursement
• The FDA approved the Abiocor for commercial approval under a Humanitarian Device Exemption in September, 2006.

Tomorrow:

• Impella breakthrough catheter products
• New products in circulatory care coming

Abiomed Presentation: Click here for PDF.